NCT02976272View on ClinicalTrials.gov

Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple

UnknownOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 7, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

January 31, 2021

Conditions
Multiple MyelomaBortezomib RegimenAdult
Interventions
OTHER

bortezomib

Trial Locations (1)

63003

RECRUITING

CHU Clermont-Ferrand, Clermont-Ferrand

Sponsors

Collaborators (1)

Laboratoires Takeda
All Listed Sponsors
collaborator

Laboratoires Takeda

INDUSTRY

lead

University Hospital, Clermont-Ferrand

OTHER